Results
21,591 records
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 33 | Sibold William JohnDirector, President and CEO |  MDGLMADRIGAL PHARMACEUTICALS, INC.Open-market sale | SELL | $777K 1,577 sh | Jan 26, 2026 |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 33 | Sibold William JohnDirector, President and CEO | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale | SELL | $777K 1,577 sh | Jan 26, 2026 |
| 33 | Tpg Gp A, Llc10% Owner |  SIONSionna Therapeutics, Inc.Open-market sale | SELL | $10.00M 250.0K sh | Jan 26, 2026 traded Jan 22, 2026 |
| 32 | Wilson Kelli AnnEVP Chief Banking Officer |  HFWAHERITAGE FINANCIAL CORP /WA/Open-market sale | SELL | $50K 1,900 sh | Jan 26, 2026 traded Jan 26, 2026 |
| 32 | Schwab-Pomerantz CarolynDirector |  SCHWSCHWAB CHARLES CORPOpen-market sale | SELL | $500K 4,765 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 32 | Bhatia Manish HEVP, Global Operations |  MUMICRON TECHNOLOGY INCOpen-market sale | SELL | $511K 1,295 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 32 | Bhatia Manish HEVP, Global Operations | MUMICRON TECHNOLOGY INC Open-market sale | SELL | $911K 2,300 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 32 | Bhatia Manish HEVP, Global Operations | MUMICRON TECHNOLOGY INC Open-market sale | SELL | $864K 2,200 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 30 | Taub RebeccaDirector | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale | SELL | $319K 647 sh | Jan 26, 2026 traded Jan 26, 2026 |
| 29 | Beckwith Van H.EVP, Secretary and CLO |  HALHALLIBURTON COOpen-market sale · 10b5-1 plan | SELL | $1.90M 54.3K sh | Jan 26, 2026 traded Jan 23, 2026 |
| 27 | O'Day Daniel PatrickDirector, Chairman & CEO |  GILDGILEAD SCIENCES, INC.Open-market sale · 10b5-1 plan | SELL | $15.61M 115.6K sh | Jan 26, 2026 traded Jan 23, 2026 |
| 25 | Huntsman CaroleChief Commercial Officer | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $282K 570 sh | Jan 26, 2026 traded Jan 26, 2026 |
| 23 | Unruch JoelGeneral Counsel/Corp Secretary |  ACNAccenture plcOpen-market sale · 10b5-1 plan | SELL | $60K 214 sh | Jan 26, 2026 traded Jan 23, 2026 |
| 23 | Unruch JoelGeneral Counsel/Corp Secretary | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $172K 610 sh | Jan 26, 2026 traded Jan 23, 2026 |
| 22 | Bachrodt AmySVP, Finance |  MAZEMaze Therapeutics, Inc.Open-market sale · 10b5-1 plan | SELL | $228K 5,000 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 21 | Mat IshbiaDirector, President and CEO, 10% Owner |  UWMCUWM Holdings CorpOpen-market sale · 10b5-1 plan | SELL | $3.64M 632.9K sh | Jan 26, 2026 traded Jan 26, 2026 |
| 21 | Urist MarshallEVP, Research & Investments |  RPRXRoyalty Pharma plcOpen-market sale · 10b5-1 plan | SELL | $805K 20.0K sh | Jan 26, 2026 traded Jan 23, 2026 |
| 20 | Unruch JoelGeneral Counsel/Corp Secretary | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $39K 138 sh | Jan 26, 2026 traded Jan 23, 2026 |
| 20 | Unruch JoelGeneral Counsel/Corp Secretary | ACNAccenture plc Open-market sale · 10b5-1 plan | SELL | $18K 64 sh | Jan 26, 2026 traded Jan 23, 2026 |
| 19 | Slowe Christopher BrianChief Technology Officer |  RDDTReddit, Inc.Open-market sale · 10b5-1 plan | SELL | $278K 1,300 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 19 | Slowe Christopher BrianChief Technology Officer | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $742K 3,487 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 19 | Slowe Christopher BrianChief Technology Officer | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $918K 4,330 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 19 | Slowe Christopher BrianChief Technology Officer | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $548K 2,600 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 19 | Slowe Christopher BrianChief Technology Officer | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $447K 2,083 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 18 | Huntsman CaroleChief Commercial Officer | MDGLMADRIGAL PHARMACEUTICALS, INC. Open-market sale · 10b5-1 plan | SELL | $167K 340 sh | Jan 26, 2026 traded Jan 26, 2026 |
| 16 | Mat IshbiaDirector, President and CEO, 10% Owner | UWMCUWM Holdings Corp Open-market sale · 10b5-1 plan | SELL | $3.71M 632.9K sh | Jan 26, 2026 traded Jan 22, 2026 |
| 16 | Mat IshbiaDirector, President and CEO, 10% Owner | UWMCUWM Holdings Corp Open-market sale · 10b5-1 plan | SELL | $3.70M 632.9K sh | Jan 26, 2026 traded Jan 23, 2026 |
| 15 | Kroeker NathanCCO and Interim CFO |  EOSEEos Energy Enterprises, Inc.Open-market sale · 10b5-1 plan | SELL | $802K 50.0K sh | Jan 26, 2026 traded Jan 26, 2026 |
| 13 | Slowe Christopher BrianChief Technology Officer | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $43K 200 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 12 | Cheng Chi FungDirector, Chief Technology Officer |  CRDOCredo Technology Group Holding LtdOpen-market sale · 10b5-1 plan | SELL | $843K 6,239 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 12 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $788K 5,744 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 12 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $543K 3,928 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 12 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $674K 5,024 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 12 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $686K 5,038 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 9 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $186K 1,400 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 9 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $71K 500 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 9 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner |  TEAMAtlassian CorpOpen-market sale · 10b5-1 plan | SELL | $471K 3,604 sh | Jan 26, 2026 traded Jan 23, 2026 |
| 9 | Cannon-Brookes MichaelDirector, CEO, Co-Founder, 10% Owner | TEAMAtlassian Corp Open-market sale · 10b5-1 plan | SELL | $376K 2,861 sh | Jan 26, 2026 traded Jan 23, 2026 |
| 9 | Cohlhepp RyanDirector, President and COO |  BCAXBicara Therapeutics Inc.Open-market sale · 10b5-1 plan | SELL | $69K 3,828 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 9 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $60K 427 sh | Jan 26, 2026 traded Jan 22, 2026 |
| 9 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $98K 700 sh | Jan 26, 2026 traded Jan 22, 2026 |